Bio-Techne (TECH) SVP Shane Bohnen Exercises Options, Net +104 Shares

What Happened
Shane Bohnen, SVP and General Counsel of Bio‑Techne (TECH), exercised 448 stock options on July 23, 2026. The exercise price was $47.60 per share (total cash paid ≈ $21,325). To satisfy tax withholding, 344 of the resulting shares were withheld/disposed at an effective price of $71.77 per share (value ≈ $24,689). The Form 4 also records a disposition of the related derivative (the option) for 448 units at $0, which reflects cancellation/conversion of the option upon exercise. Net result: Bohnen retained 104 shares (448 exercised − 344 withheld).

Key Details

• Transaction date: 2026-07-23; Form filed 2026-07-27 (filed within standard two business days).
• Option exercise: 448 shares exercised at $47.60/share (total ≈ $21,325).
• Tax withholding: 344 shares withheld/paid at $71.77/share (value ≈ $24,689).
• Derivative disposition: 448 options reported disposed at $0 (reflects conversion of the options).
• Net shares acquired: 104 shares added to beneficial ownership.
• Shares owned after transaction: not specified in the provided filing extract.
• Footnote(s): filing includes footnote F1 (“Fully exercisable”) and related grant/vesting notes; F code meanings here — M = option exercise/conversion, F = payment of exercise price or tax liability (withholding).

Context
This was an option exercise followed by company withholding of shares to cover taxes (a common cashless or net-share settlement element). The withheld shares are not an open-market sale for cash proceeds to the insider; they simply satisfy tax obligations. The derivative disposition at $0 is the routine cancellation of the exercised options. The net increase of 104 shares is modest; filings like this are factual disclosures and not direct evidence of future company performance.